Replimune
REPL
#6475
Rank
NZ$1.51 B
Marketcap
NZ$18.07
Share price
-2.70%
Change (1 day)
226.63%
Change (1 year)

Market capitalization of Replimune (REPL)

Market cap: NZ$1.51 Billion

As of July 2026 Replimune has a market cap of NZ$1.51 Billion. This makes Replimune the world's 6475th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Replimune from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$1.51 B12.45%
2025NZ$1.34 B-19.36%
2024NZ$1.67 B112.5%
2023NZ$0.78 B-63.05%
2022NZ$2.13 B14.53%
2021NZ$1.86 B-23.44%
2020NZ$2.43 B211.23%
2019NZ$0.78 B65.53%
2018NZ$0.47 B

End of Day market cap according to different sources

On Jul 23rd, 2026 the market cap of Replimune was reported to be:

NZ$1.51 Billion
by Nasdaq info icon info icon
NZ$1.51 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.94 B 28.39%๐Ÿ‡บ๐Ÿ‡ธ USA